Abstract:Abstract Background HIV-1 Tat activates RNA Polymerase II (RNAP II) elongation of the integrated provirus by recruiting a protein kinase known as P-TEFb to TAR RNA at the 5 ′ end of nascent viral transcripts. The catalytic core of P-TEFb contains CDK9 and Cyclin T1 (CCNT1). A human endogenous complexome has recently been described – the set of multi-protein complexes in HeLa cell nuclei. We mined this complexome data set and identified 12 distinct multi-protein complexes that contain both CDK9 and CCNT1. We have termed these complexes CCAPs for C DK9/ C CNT1- a ssociated p rotein complexes. Nine CCAPs are novel, while three were previously identified as Core P-TEFb, the 7SK snRNP, and the Super-Elongation Complex. We have investigated the role of five newly identified CCAPs in Tat function and viral gene expression. Results We examined five CCAPs that contain: 1) PPP1R10/TOX3/WDR82; 2) TTF2; 3) TPR; 4) WRNIP1; 5) FBXO11/CUL1/SKP1. SiRNA depletions of protein subunits of the five CCAPs enhanced Tat activation of an integrated HIV-1 LTR-Luciferase reporter in TZM-bl cells. Using plasmid transfection assays in HeLa cells, we also found that siRNA depletions of TTF2, FBXO11, PPP1R10, WDR82, and TOX3 enhanced Tat activation of an HIV-1 LTR-luciferase reporter, but the depletions did not enhance expression of an NF-κB reporter plasmid with the exception of PPP1R10. We found no evidence that depletion of CCAPs perturbed the level of CDK9/CCNT1 in the 7SK snRNP. We also found that the combination of siRNA depletions of both TTF2 and FBXO11 sensitized a latent provirus in Jurkat cells to reactivation by sub-optimal amounts of αCD3/CD28 antibodies. Conclusions Our results identified five novel CDK9/CCNT1 complexes that are capable of negative regulation of HIV-1 Tat function and viral gene expression. Because siRNA depletions of CCAPs enhance Tat function, it is possible that these complexes reduce the level of CDK9 and CCNT1 available for Tat, similar to the negative regulation of Tat by the 7SK snRNP. Our results highlight the complexity in the biological functions of CDK9 and CCNT1.

AID Recruits the RNA Exosome to Degrade HIV ‐1 Nascent Transcripts Through Interaction with the Tat‐P‐ TEF B‐ TAR RNP Complex

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency

SAMHD1:a new HIV-1 inhibitory factor

Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

The TAR Binding Dynamics and Its Implication in Tat Degradation Mechanism

The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates.

Vif Hijacks CBF-β to Degrade APOBEC3G and Promote HIV-1 Infection

Adeno-Associated Virus (AAV)-Delivered Exosomal TAT and BiTE Molecule CD4-αCD3 Facilitate the Elimination of CD4 T Cells Harboring Latent HIV-1

Interaction of the Second Coding Exon of Tat with Human Ef-1 Delta Delineates A Mechanism for Hiv-1-Mediated Shut-Off of Host Mrna Translation

HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.

Role of TAR RNA Binding Protein in HIV-1 Infection

hsa-miR-181-5p inhibits human immunodeficiency virus type 1 replication by downregulating DDX3X expression

A Cofactor, TIP30, Specifically Enhances HIV-1 Tat-activated Transcription.

Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function

The HIV-1 Tat Protein Recruits a Ubiquitin Ligase to Reorganize the 7SK Snrnp for Transcriptional Activation

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase

APOBEC3 proteins and reverse transcription